REPL INVESTOR ALERT: Securities Class Action Filed Against Replimune Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
Kirby McInerney LLP announced that a class action lawsuit has been filed against Replimune Group, Inc. on behalf of investors who purchased securities between October 20, 2025 and April 10, 2026. The lawsuit alleges the company failed to address FDA study design concerns regarding its BLA for RP1 and submitted insufficient data from early analyses.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.